Skip to main content
. 2017;18(11):3017–3023. doi: 10.22034/APJCP.2017.18.11.3017

Table 5.

Bivariate Analysis of Delay and No Delay in Treatment Onset according to Clinical-Pathological Variables, Brazil, 2015

Variables Delay (> 30 days) No delay (≤ 30 days) p
n (%) n (%)
Tumor stage (n=62)
 I 1 (50.0) 1 (50.0)
 IIA and IIB 23 (62.2) 14 (37.8)
 IIIA and IIIB 13 (61.9) 8 (38.1)
 IV 1 (50.0) 1 (50.0) 0.97
Estrogen receptor (n=68)
 Positive 34 (63.0) 20 (37.0)
 Negative 10 (71.4) 4 (28.6) 0.45
Progesterone receptor (n=66)
 Positive 32 (65.3) 17 (34.7)
 Negative 11 (64.7) 6 (35.3) 0.96